How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

키워드

참고문헌 (17)

1. Oh H, "Non-alcoholic fatty liver diseases : update on the challenge of diagnosis and treatment", Clin Mol Hepatol, 22, pp.327~335 (2016)
2. Wang MM, "Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors", Dig Dis Sci, 59, pp.2571~2579 (2014)
3. Wong VW, "Hepatitis B virus infection and fatty liver in the general population", J Hepatol, 56, pp.533~540 (2012)
4. Machado MV, "Hepatic steatosis in hepatitis B virus infected patients : meta-analysis of risk factors and comparison with hepatitis C infected patients", J Gastroenterol Hepatol, 26, pp.1361~1367 (2011)
5. Sass DA, "Nonalcoholic fatty liver disease : a clinical review", Dig Dis Sci, 50, pp.171~180 (2005)
6. Peng XE, "The roles of HBV infection and host factors in ultrasound-diagnosed fatty liver : a case-control study", Hepatogastroenterology, 60, pp.1698~1704 (2013)
7. Kim KH, "Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma", Gastroenterology, 132, pp.1955~1967 (2007)
8. Kim K, "Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha", Biochem J, 416, pp.219~230 (2008)
9. Ceylan B, "Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir", Turk J Gastroenterol, 27, pp.42~46 (2016)
10. Zhu Y, "The effect of hepatosteatosis on response to antiviral treatment in patients with chronic hepatitis B : a metaanalysis", Gastroenterol Res Pract, 2017, pp.1096406~ (2017)
11. Hu D, "Nonalcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model", Hepatol Int, 12, pp.438~446 (2018)
12. Zhang Z, "Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model", J Gastroenterol Hepatol, 27, pp.1858~1864 (2012)
13. Chou HH, "Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota", Proc Natl Acad Sci U S A, 112, pp.2175~2180 (2015)
14. Yoon CH, "Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area", Eur J Gastroenterol Hepatol, 30, pp.1090~1096 (2018)
15. David Sooik Kim, "Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir", Clinical and Molecular Hepatology, 25(3), pp.283~293 (2019), 대한간학회
16. Seto WK, "Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis B", Clin Gastroenterol Hepatol, 16, pp.575~583 (2018)[DOI]
17. Lee DH, "Imaging evaluation of non-alcoholic fatty liver disease : focused on quantification", Clin Mol Hepatol, 23, pp.290~301 (2017)

관련 논문AI추천